Koyfin Home > Directory > Health Care > Intellia Thera CS > Enterprise Value

Intellia Thera CS Enterprise Value Chart (NTLA)

Intellia Thera CS annual/quarterly Enterprise Value from 2016 to 2020.
  • Intellia Thera CS Enterprise Value for the quarter ending October 10, 2020 was $966m a -13.86% decrease of -134m year over year
  • Intellia Thera CS Enterprise Value for the last 12 months ending October 10, 2020 was $966m a -13.86% decrease of -134m year over year
  • Intellia Thera CS Annual Enterprise Value for 2020 was $966m a 0.00% decrease of 0m from 2019
  • Intellia Thera CS Annual Enterprise Value for 2020 was $966m a -5.23% decrease of -51m from 2019
  • Intellia Thera CS Annual Enterprise Value for 2020 was $1,017m a -8.20% decrease of -83m from 2019
Other Valuation Metrics:
  • Intellia Thera CS Market Cap for the quarter ending June 06, 2018 was $1,179m a 23.88% increase of 282m year over year
  • Intellia Thera CS Price / Book for the quarter ending June 06, 2018 was 3.99 a -19.74% decrease of -0.79 year over year
View Chart On Koyfin

Quarterly NTLA Enterprise Value Data

10/2020$966m
10/2020$966m
10/2020$1,017m
10/2020$1,100m
10/2020$1,120m
10/2020$1,011m
10/2020$1,038m
10/2020$1,032m
10/2020$991m
10/2020$1,132m

Annual NTLA Enterprise Value Data

2020$966m
2020$966m
2020$1,017m
2020$1,100m
2020$1,120m
2020$1,011m
2020$1,038m
2020$1,032m
2020$991m
2020$1,132m